🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.

Several experts said the demand for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Material Elimination

Based on TikTok, the service has taken down problematic content and banned related hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Digital Trading Operations

Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, glowing reviews and detailed guides for mixing or administering at home.

After minutes of joining one community, a seller posted contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, health issues or past usage.

Product Information and Pricing

Inside these groups, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly significant health risks”.